Prevent. Restore. Preserve.

We use the power of science to alleviate suffering through
preventive and restorative medicine

Learn morecontribute
IN COLLABORATION WITH

Activities

Funding research to develop interventions which remediate the molecular damage underlying the diseases of ageing
Public outreach and advocacy for ageing research
Evaluating the impact of biomedical discoveries on the economy
Hosting seminars and conferences
Encouraging young scientists to specialize in the areas of biogerontology
Acting as a think tank for ageing research policy
Establishing strategic partnerships to galvanize progress in biomedical gerontology

What we do

The objective of research conducted or funded by the Biogerontology Research Foundation (the BGRF) is to produce effective cures or treatments for the diseases and frailty commonly associated with ageing in the human population

BOARD OF TRUSTEES

Dmitry Kaminsky
MANAGING TRUSTEE

Dmitry Kaminskiy is a new generation entrepreneur and well-known visionary originally from Eastern Europe. He has been concentrating on developing his business in East Asia as a priority in recent years. Dmitry built his wealth on IT-solutions, analytics and predictions for private banking, financial engineering and rapidly growing industries. He is known for his experience in information technology, advanced computer science and development of advanced Big Data industrial expert analytical systems. He has a wide network spanning the scientific and business communities across the globe.Inspired by breakthrough antiaging research Dmitry decided to apply his high-level computer developing infrastructure to analyze complex unstructured Big Data in biomedicine and longevity in particular to find a real breakthrough therapies to treat age-related diseases and prolong active and productive longevity.Becoming a trustee of the Biogerontology Research Foundation (BGRF) in London, founded in 2007, was the logical next step of his mission. BGRF supports research on aging, addressing the challenges of a rapidly aging population. Their research was aimed to reduce the impact of age-related diseases on future generations.

Alex Zhavoronkov
TRUSTEE

Alex Zhavoronkov PhD, is the director and a trustee of the Biogerontology Research Foundation. He heads the laboratory of regenerative medicine at the Clinical Research Center for Pediatric Hematology, Oncology and Immunology where his research interests include Hutchinson-Gilford Syndrome, new methods of cellular reprogramming, molecular mechanisms of skin and cartilage regeneration and personalized medicine in oncology. He is also the international adjunct professor at the Moscow Institute of Physics and Technology. He is the CEO and co-founder of InSilico Medicine, Inc., a Baltimore-based company utilizing Big Data analysis for aging research and drug discovery.Dr Zhavoronkov is the author of multiple peer-reviewed scientific as well as popular papers and books on the many aspects of biogerontology, aging research and aging economics including “The Ageless Generation: how biomedical advances will transform the global economy” published by Palgrave Macmillan. He holds two bachelor degrees from Queen’s University, a masters in biotechnology from Johns Hopkins Universtity and a PhD in physics and mathematics from the Moscow State University.

João Pedro de Magalhães
TRUSTEE

Dr de Magalhaes, a trustee of the Biogerontology Research Foundation, graduated in Microbiology in 1999 from the Escola Superior de Biotecnologia in his hometown of Porto, Portugal, and then obtained his PhD in 2004 from the University of Namur in Belgium, where he worked in the Ageing and Stress Group led by Dr Olivier Toussaint. Following a postdoc with genomics pioneer Prof George Church at Harvard Medical School in Boston, USA, in 2008 Dr de Magalhaes was recruited to the University of Liverpool in the UK to develop his own group on genomic approaches to ageing. Now a senior lecturer, Dr de Magalhaes leads the Integrative Genomics of Ageing Group (http://pcwww.liv.ac.uk/~aging/) which focuses on understanding the genetic, cellular, and molecular mechanisms of ageing. The group’s research integrates different strategies, but its focal point is developing and applying experimental and computational methods that help bridge the gap between genotype and phenotype, a major challenge of the post-genome era, and help decipher the human genome and how it regulates complex processes like ageing. Notably, his group is a world-leader in employing genomics and bioinformatics to study ageing with pioneering work in studying gene networks of ageing and in sequencing and analyzing genomes from long-lived species. Dr de Magalhaes has given over 100 invited talks, including a TEDx talk, and his research has been widely featured  in the popular press (BBC, CNN, the Washington Post, the Financial Times and many others).

Administrative Staff

Franco Cortese
DEPUTY DIRECTOR

Franco Cortese is the Deputy Director of the Biogerontology Research Foundation. His focus as Deputy Director of the BGRF centers upon contributing to long-term planning and strategizing of BGRF activities, including research directions, strategic partnerships and collaborations, as well as regulatory and public policy proposals, position statements and recommendations. Meanwhile, his focus as an Affiliated Researcher of the Biogerontology Research Foundation centers upon the study and development of biomedical and biotechnological interventions for ageing and age-related pathology. He believes that the most effective and economic approach to the treatment of age-related disease – which represent from both a quantitative and qualitative standpoint some of the most significant diseases afflicting humanity today – is through the extension of healthspan via biomedical interventions focusing on the prevention, negation and/or slowing of accumulated age-related phenotypic deviation. In addition to his administrative and research activities, Cortese has also written extensively on the ethical, socioeconomic, political, logistical and philosophical implications of biomedical gerontology. Cortese’s other current positions and affiliations include Research Scientist at ELPIs Foundation for Indefinite Lifespans, Affiliate Scholar at the Institute for Ethics & Emerging Technologies Scientific Advisor for Lifeboat Foundation (Life Extension Advisory Board and Futurists Advisory Board), Honorary Fellow (and former Secretary) of Brighter Brains Institute, Chief Operating Officer of the Center for Interdisciplinary Philosophic Studies, International Coordinator of Cryonics Switzerland, Ambassador for the Seasteading Institute, Assistant Editor at Ria University Press, member of the International Longevity Alliance, Chair and Co-Founder of the Canadian Longevity Alliance, and Reviewer for the Global Futures Intelligence System at The Millennium Project.

Igor Filipiuk
MANAGER

Educated in finance and biotechnology at Warsaw School of Economics and Warsaw University. Igor is experienced in biz-dev an early-stage biotech companies aiming to change the paradigm of usage of antimicrobial agents. Igor also made a substantial contribution into developing business and academia relationships with leaders in Eastern Europe Region.Igor is also a member of non-profit organization Boost Biotech which focuses on popularizing knowledge about life sciences. Igor is interested in using multi-disciplinary approach in order to promote advancement in healthcare and life sciences.

Sven Bulterijs
MANAGER

Sven Bulterijs has studied biochemistry and biotechnology at the University of Ghent (Belgium) and has worked on a research project for the SENS research foundation at Yale University. Sven Bulterijs is one of the founding members of the Belgian NGO Heales, an editor of the Longevity Reporter and a director of Longecity.He has published multiple peer-reviewed papers and has given lectures at multiple international conferences. He is a long-time proponent of life extension, and has been involved in advocacy and outreach for many years.

Victor Bjoerk
MANAGER

Victor is a graduate student in Molecular biology at Uppsala University, He is since many years interested in biogerontology and has been involved in Longevity advocacy for many years.He is a outreach coordinator of Heales and administrative assistant at GRG, a scientific organisation researching the oldest people on earth, and has published papers as well as been a speaker at scientific conferences. He also publishes articles for Longevity reporter.

Jakub Stefaniak
MANAGER

Is a Oxford University biochemistry graduate with a strong interest in pharmacology, Jakub understands why in the 21st century we need to rethink drug discovery given the rising costs and diminishing returns that pharmaceutical companies are increasingly facing. With an increase in the reliance on biomarkers and in silico methods in bioscience, Jakub is currently pursuing a Doctoral Training Programme at the University of Oxford, where he tries to augment his biochemical knowledge with mathematical and computational skills.He is also the Vice-President of the Oxford University Scientific Society. His scientific interests include personalized and stratified medicine and artificial intelligence.

Robert James Powles
MANAGER

A graduate student of Biochemistry and intern at the Biogerontology Research Foundation, Robert is a passionate biogerontology and longevity advocate with a specific focus on regenerative medicine.Currently editor at The Longevity Reporter, a website dedicated to longevity, healthcare and aging related news, Robert has also completed a prior degree in BA Film Production and is focused on combining scientific rigour within a multidisciplinary approach to solving the ethical and practical challenges posed by aging and age-related disease.

Affiliated Researchers

Franco Cortese
AFFILIATED RESEARCHER

Franco Cortese is the Deputy Director of the Biogerontology Research Foundation. His focus as Deputy Director of the BGRF centers upon contributing to long-term planning and strategizing of BGRF activities, including research directions, strategic partnerships and collaborations, as well as regulatory and public policy proposals, position statements and recommendations. Meanwhile, his focus as an Affiliated Researcher of the Biogerontology Research Foundation centers upon the study and development of biomedical and biotechnological interventions for ageing and age-related pathology. He believes that the most effective and economic approach to the treatment of age-related disease – which represent from both a quantitative and qualitative standpoint some of the most significant diseases afflicting humanity today – is through the extension of healthspan via biomedical interventions focusing on the prevention, negation and/or slowing of accumulated age-related phenotypic deviation. In addition to his administrative and research activities, Cortese has also written extensively on the ethical, socioeconomic, political, logistical and philosophical implications of biomedical gerontology. Cortese’s other current positions and affiliations include Research Scientist at ELPIs Foundation for Indefinite Lifespans, Affiliate Scholar at the Institute for Ethics & Emerging Technologies Scientific Advisor for Lifeboat Foundation (Life Extension Advisory Board and Futurists Advisory Board), Honorary Fellow (and former Secretary) of Brighter Brains Institute, Chief Operating Officer of the Center for Interdisciplinary Philosophic Studies, International Coordinator of Cryonics Switzerland, Ambassador for the Seasteading Institute, Assistant Editor at Ria University Press, member of the International Longevity Alliance, Chair and Co-Founder of the Canadian Longevity Alliance, and Reviewer for the Global Futures Intelligence System at The Millennium Project.

‍Franco Cortese
Affiliated Researcher